103 related articles for article (PubMed ID: 32985060)
1. Self-management among pre-teen and adolescent diabetes device users.
Faulds ER; Hoffman RP; Grey M; Tan A; Tubbs-Cooley H; Militello LK; Happ MB
Pediatr Diabetes; 2020 Dec; 21(8):1525-1536. PubMed ID: 32985060
[TBL] [Abstract][Full Text] [Related]
2. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
3. Characterization of youth goal setting in the self-management of type 1 diabetes and associations with HbA1c: The Flexible Lifestyle Empowering Change trial.
Cristello Sarteau A; Crandell J; Seid M; Kichler JC; Maahs DM; Wang J; Mayer-Davis E
Pediatr Diabetes; 2020 Nov; 21(7):1343-1352. PubMed ID: 32741045
[TBL] [Abstract][Full Text] [Related]
4. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
[TBL] [Abstract][Full Text] [Related]
5. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
[TBL] [Abstract][Full Text] [Related]
6. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
7. Expect the unexpected: Adolescent and pre-teens' experience of diabetes technology self-management.
Faulds ER; Grey M; Tubbs-Cooley H; Hoffman RP; Militello LK; Tan A; Happ MB
Pediatr Diabetes; 2021 Nov; 22(7):1051-1062. PubMed ID: 34263953
[TBL] [Abstract][Full Text] [Related]
8. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
[TBL] [Abstract][Full Text] [Related]
9. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
[TBL] [Abstract][Full Text] [Related]
10. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
[TBL] [Abstract][Full Text] [Related]
11. Novel predictors of daily fluctuations in glycemia and self-management in adolescents and young adults with type 1 diabetes.
Messer LH; Vigers T; Pyle L; Fivekiller E; Wadwa RP; Hernandez TL; Cook PF
Diabet Med; 2022 Sep; 39(9):e14910. PubMed ID: 35776655
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
[TBL] [Abstract][Full Text] [Related]
13. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Rodbard D
Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
[TBL] [Abstract][Full Text] [Related]
14. Body mass index moderates the association between diabetes distress and objective self-management behaviours in adolescents with type 1 diabetes and elevated A1Cs.
Trojanowski PJ; Pardon A; Reynolds C; O'Donnell HK; Alonso GT; Majidi S; Snell-Bergeon J; Wadwa RP; Driscoll KA
Diabet Med; 2024 Jul; 41(7):e15325. PubMed ID: 38551326
[TBL] [Abstract][Full Text] [Related]
15. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
[TBL] [Abstract][Full Text] [Related]
16. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
17. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
Parise M; Tartaglione L; Cutruzzolà A; Maiorino MI; Esposito K; Pitocco D; Gnasso A; Irace C
J Med Internet Res; 2021 Apr; 23(4):e24552. PubMed ID: 33769945
[TBL] [Abstract][Full Text] [Related]
18. Observed Characteristics Associated with Diabetes Device Use Among Teens with Type 1 Diabetes.
Chen CW; Tinsley LJ; Volkening LK; Anderson BJ; Laffel LM
J Diabetes Sci Technol; 2023 Jan; 17(1):186-194. PubMed ID: 34652236
[TBL] [Abstract][Full Text] [Related]
19. Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry.
Šumník Z; Pavlíková M; Pomahačová R; Venháčová P; Petruželková L; Škvor J; Neumann D; Vosáhlo J; Konečná P; Čížek J; Strnadel J; Průhová Š; Cinek O;
Pediatr Diabetes; 2021 May; 22(3):439-447. PubMed ID: 33533545
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
